“Together, Pfizer and Seagen seek to accelerate the next generation of cancer breakthroughs and bring new solutions to patients by combining the power of Seagen’s antibody-drug conjugate technology with the scale and strength of Pfizer’s capabilities and expertise," says Pfizer Chairman and CEO Albert Bourla, PhD.

Laura Perryman, the former chief of Florida-based Stimwave, allegedly created a non-functioning “dummy device” that was used to treat patients suffering from chronic pain.

The REDI Act would allow physicians-in-training to qualify for interest-free deferment of their student loans while serving in a medical internship or residency program.

Radiologists and pain management specialists are urging CMS to reconsider the decision and maintain access to this alternative to opioids or surgery. 

CVS Caremark, Express Scripts and OptumRx have been asked to provide documents, communications and information related to their practices.

The Food and Drug Administration has put in for a $7.2 billion chunk of the $6.9 trillion federal budget for fiscal year 2024 that President Joe Biden proposed March 9.

The administration also is strengthening its ability to oversee imaging providers and enforce standards in the Mammography Quality Standards Act. 

SCAI and the Association of Black Cardiologists have joined forces to share a simple message: PAD patients would be negatively impacted by new CMS proposals.